Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 19Breast Neoplasms 12Brain Neoplasms 11Agnosia 7Neoplasms 6Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Lung Neoplasms 4Pituitary Neoplasms 3Pain 3Inflammation 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Thrombosis 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1

Interventions

Imatinib Mesylate 3mirdametinib 2tipifarnib 1talimogene laherparepvec 1pirfenidone 1nilotinib 1emvododstat 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Magnetic Resonance Spectroscopy 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neurofibromatoses × Dexmedetomidine × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡